New NASMHPD Paper Examines Opportunities to Strengthen Tardive Dyskinesia Screening Across State Mental Health Systems

Tardive dyskinesia (TD) remains a common yet often underrecognized movement disorder associated with antipsychotic medications. NASMHPD’s new policy paper, Advancing Screening for Tardive Dyskinesia: Promoting Early Detection and Care Across State Mental Health Systems for Individuals with Serious Mental Illness, explores the role state mental health authorities can play in improving early identification, monitoring, and treatment of TD. The paper highlights current evidence, clinical guidelines, and findings from a national survey of state mental health leaders regarding TD screening. It outlines a roadmap for state mental health agencies seeking to strengthen TD screening through policy leadership, workforce support, technology-enabled clinical workflows, and person-centered engagement strategies. This paper was funded by Neurocrine Biosciences. Acceptance of corporate funds does not imply NASMHPD endorsement of a company’s products, services, programs, or activities. Learn more about the TD Screening Initiative.